Kenya Diabetic Retinopathy Market Analysis


  • Type: Common Disease Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4912

  • Format: PPT, PDF

Kenya Diabetic Retinopathy Drug Market: Segmented by Treatment Type (Anti-VEGF Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), Route of Administration (Oral and Injectable) and Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Growth, Trends, And Forecasts (2019 – 2028)

SKU: 4912 Categories: ,

Report Overview

The Diabetic Retinopathy drug market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Diabetic Retinopathy (DR) is a major complication of diabetes, where damage to the retina is caused by micro-vascular damage to retinal vessels. If untreated, diabetic retinopathy leads to progressive vision loss and eventually blindness. The World Health Organization (WHO) estimates that the prevalence of diabetes in Kenya at 3.3% and predicts a rise to 4.5% by 2025. However, two-thirds of diabetics may be undiagnosed. DR has a negative impact on the quality of life. People with severe vision loss require additional health resources and endure reduced levels of physical, emotional and social well-being. Improved serum lipid and blood pressure control can also slow the progression of retinopathy, especially when initiated soon after the diagnosis of diabetes.

Market Drivers

The market is majorly driven by the increasing prevalence of diabetes and complications arising due to poor glycaemic control like Diabetic Retinopathy in Kenya. It is estimated that one in every three people with diabetes develop diabetic retinopathy. A study in Kenya found a prevalence of 35.9%.

The country is experiencing a rise in diabetes owing to demographic, nutritional and social changes such as urbanization.

The Development of new and improved drugs and advancement of technologies is expected to propel growth in the diabetic retinopathy drug market.

Increasing initiatives by Government of Kenya by implementation of National Diabetes Strategy and releasing guidelines for screening and management of Diabetic Retinopathy. A Diabetes Education Programme has also been implemented for healthcare staff.

However, there is a high unmet need for DR services in the country, which highlights the need to strengthen health systems. The barriers are lack of referral and inadequate knowledge of diabetes eye health.

1. Kenya Diabetic Retinopathy Drug Market Overview………………………………
A. Market Size
2. Market Growth Drivers……………………………………………………………
A. Increase in the Prevalence of Diabetes and Its Complications in Kenya
B. Implementation of National Diabetes Strategy and Other Government Initiatives to Prevent, Control and Manage Diabetes and Related Complications
C. Development of New Drugs
3. Major Diabetic Retinopathy Types…………….………………………………….
A. Proliferative Diabetic Retinopathy
B. Non-Proliferative Diabetic Retinopathy
4. Diabetic Retinopathy Drug Market Segmentation………………………………….
A. Treatment Type
I. Anti-VEGF Therapy
II. Intraocular Steroid Injection
III. Laser Surgery
IV. Vitrectomy
V. Others
B. Route of Administration
I. Oral
II. Injectable
C. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Diabetic Retinopathy Major Drugs Market Share…………………………….
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape……………………………………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………
A. F. Hoffmann La-Roche Company overview, Product & Services, Strategies & Financials
B. Bayer Company overview, Product & Services, Strategies & Financials
C. Bristol Myers Squibb Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………….
A. New Trends and Development of Diabetic Retinopathy drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Treatment Type:

On the basis of treatment type, the market can be segmented into Anti-Vascular Endothelial Growth Factor Therapy, Intraocular Steroid Injection, Laser Surgery and Vitrectomy.

The anti-VEGF segment dominates the market owing to high applicability of these drugs in treatment of mild to moderate cases of non-proliferative DR and faster recovery. The major anti-VEGF agents currently used include Eylea, Avastin, Lucentis, and Macugen.

By Route of Administration:

On the basis of route of administration, the market can be segmented into Oral and Injectables.

Kenalog-40 (Bristol-Myers Squibb) is the most commonly used intraocular steroid and has been widely utilized as intravitreal injections since 2004 for the treatment of several retinal diseases.

By Distribution Channel:

On the basis of distribution channel, the market for diabetes drugs can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others.

Retail pharmacy segment holds the dominant share and is projected to high growth rates throughout the forecast period.

Major Players

The key players operating in the Diabetic Retinopathy Drug Market in Kenya are F. Hoffmann La- Roche AG, Pfizer, Inc. Bayer, Allergan PLC, Novartis AG, and others.

The most frequently used anti-VEGF drugs are Roche/Genentech’s humanized antibodies Lucentis (ranibizumab) and Avastin (bevacizumab), and Bayer/Regeneron’s fusion protein Eylea (aflibercept).

Kenalog-40 manufactured by Bristol-Myers Squibb is the most commonly used intraocular steroid.

Development of new drugs in leading to high growth in the diabetic retinopathy drug market. For instance, in April 2019, Novartis received approval for brolucizumab, an ophthalmic drug.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements